Viewing Study NCT02171195


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-02-26 @ 4:17 PM
Study NCT ID: NCT02171195
Status: COMPLETED
Last Update Posted: 2016-07-20
First Post: 2014-06-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
Sponsor: Bial - Portela C S.A.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epilepsy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eslicarbazepine acetate View
None BIA 2-093 View
None Epilepsy View